YCW19· Other

Intact Therapeutics

Smart gels for local drug delivery to the gut

ActiveChecked 19h ago

Batch: W19
Status, per YC: Active
Team size: 4
HQ: San Francisco, CA

In W19194 companies, 26% AI

intacttherapeutics.com YC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

Competitors

Closest in what they build, same category.

Avro Life ScienceW18Skin patches for generic drug delivery.Shared: drug deliveryActive

Adjacent

Overlapping tags, a different niche.

NanograbS23Deliver genes to any cell with AIShared: drug delivery, therapeuticsActive
KeylikaS22Redefining the Standard of Care for Iron Deficiency AnemiaShared: drug delivery, therapeuticsActive
SynsoryBioW24"If-then" conditional logic for protein drugsShared: therapeuticsActive
Gerostate AlphaS18Developing novel therapeutics for aging and chronic diseaseShared: therapeuticsInactive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: therapeuticsActive

Also from W19

Batchmates in Winter 2019.

About Intact Therapeutics

Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.

San Francisco, CA, USA; Los Altos, CA, USA

Intact Therapeutics: questions

Which YC batch was Intact Therapeutics in?

Intact Therapeutics was in Y Combinator's Winter 2019 batch (W19).

Is Intact Therapeutics still active?

Y Combinator lists Intact Therapeutics as active.

Where is Intact Therapeutics based?

Intact Therapeutics lists San Francisco, CA, USA; Los Altos, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.